Fundraising Fox
ARS Pharmaceuticals
San Diego, US · Founded 2015 · 5 known investors
Find your way into ARS Pharmaceuticals
Sign up to see every warm intro you have to ARS Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ARS Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ARS Pharmaceuticals is a biopharmaceutical company developing treatments for severe allergic reactions, with a focus on patient-friendly, easy-to-use intranasal therapies. It serves patients with allergies and their caregivers.
Founders & leadership
ARS Pharmaceuticals was founded in 2015 by Richard Lowenthal.
Board
Investors · 5
How we know: Nextech Invest's portfolio page · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: RA Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
How we know: SR One Capital Management's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$63M disclosed across 2 rounds · 2018–2021
▶$55MraisedSep 2021 · 8 investors · PharmaceuticalsRule 506(b)
- Rajeev DadooDirector
- Peter KolchinskyDirector
- Mike KellyDirector
- Brent SaundersDirector
- Richard LowenthalExecutive Officer, Director
- Dana McGowanExecutive Officer
- Pratik ShahDirector
- Jonathan LeffDirector
- Phil SchneiderDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedOct 2018 · 2 investors · PharmaceuticalsRule 506(b)
- Jonathan LeffDirector
- Richard LowenthalExecutive Officer, Director
- Pratik ShahDirector
- Offering amount
- $20M
- Amount sold
- $8M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does ARS Pharmaceuticals do?
- ARS Pharmaceuticals is a biopharmaceutical company developing treatments for severe allergic reactions, with a focus on patient-friendly, easy-to-use intranasal therapies. It serves patients with allergies and their caregivers.
- Who founded ARS Pharmaceuticals?
- ARS Pharmaceuticals was founded by Richard Lowenthal in 2015.
- Who are ARS Pharmaceuticals's investors?
- ARS Pharmaceuticals's investors include Nextech Invest, OrbiMed, RA Capital, SR One Capital Management, Sofinnova Ventures.
- How much funding has ARS Pharmaceuticals raised?
- ARS Pharmaceuticals has disclosed $63M raised across 2 rounds.
- Where is ARS Pharmaceuticals headquartered?
- ARS Pharmaceuticals is headquartered in San Diego, US.